PTJ
MED icon

Paul Tudor Jones’s Medifast MED Stock Holding History

Paul Tudor Jones’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,100
Closed -$190K – 3560
2025
Q1 		$190K Sell
14,100
-4,400
-24% -$66.1K ﹤0.01% 2877
2024
Q4 		$326K Buy
+18,500
New +$343K ﹤0.01% 2526
2023
Q3 		– Sell
-2,600
Closed -$240K – 2631
2023
Q2 		$240K Buy
+2,600
New +$231K ﹤0.01% 2133
2023
Q1 		– Sell
-1,900
Closed -$221K – 2745
2022
Q4 		$221K Buy
+1,900
New +$221K ﹤0.01% 2086

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Paul Tudor Jones's MED Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Medifast (MED) in Q2 2026: 76,031 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #2563 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in MED as recently as Q2 2024.

Paul Tudor Jones first reported a position in MED in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.81M in Q2 2019. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Paul Tudor Jones held 76,031 shares of Medifast worth $807K as of Q2 2026.
  • Medifast was a new Paul Tudor Jones position in Q2 2026.
  • Medifast made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2563 holding.
  • Paul Tudor Jones first reported a position in Medifast in Q2 2013 and has held it in 17 quarters since.
  • Paul Tudor Jones's Medifast position peaked at $3.81M in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.